Lapatinib Intermediate CAS 231278-84-5 Puritas >98.0% (HPLC) Imago Featured

Lapatinib Intermedia CAS 231278-84-5 Puritas >98.0% (HPLC)

Description:

5-[4-[3-Chloro-4-(3-Fluorobenzyloxy)anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde

CAS: 231278-84-5 .

Puritas: >98.0% (HPLC)

Aspectus: Pallidus ad Yellow solidus pulveris

Medium API (CAS 388082-77-7)

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Lapatinib intermedia:

Lapatinib Base	CAS 231277-92-2
Lapatinib Ditosylate Monohydrate	CAS 388082-78-8
Sodium Methanesulfinate	CAS 20277-69-4
3-Chloro-4-(3-Fluorobenzyloxy)aniline	CAS 202197-26-0
2-Aminoethyl Methyl Sulfone Hydrochloridis	CAS 104458-24-4
4-Chloro-6-Iodoquinazoline	CAS 98556-31-1
6-Iodo-4-Hydroxyquinazoline	CAS 16064-08-7
5-Formyl-2-Acidi Furanboronic	CAS 27329-70-0
5-[4-[3-Chloro-4-(3-Fluorobenzyloxy)anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde	CAS 231278-84-5

Chemical Properties:

Nomen chemicum	5-[4-[3-Chloro-4-(3-Fluorobenzyloxy)anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde
Synonyma	Lapatinib Medium 3;5-[4-[[3-Chloro-4-[(3-Fluorophenyl)methoxy]phenyl]amino]-6-Quinazolinyl]-2-Furancarboxaldehyde;5-[4-((3-Chloro-4-((3-Fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-Furaldehyde
CAS Number	231278-84-5
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C26H17ClFN3O3
M. Pondus	473.90
Liquescens punctum	225.0 ad 235.0℃
Density	1.407±0.06 g/cm3
Index refractivus	1.694
COA & MSDS	Praesto
Origin	Shanghai, China
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Pallidus ad Yellow solidus pulveris
Puritas / Analysis Methodus	>98.0% (HPLC)
Liquescens punctum	225.0~235.0℃
Damnum in Siccatio	<1.00%
Residere in Ignition	<0.50%
Totalis immunditias	<2.00%
Metalla gravia (ut Pb)	<20ppm
Test Standard	Enterprise Standard
Consuetudinem	Medium API (CAS 388082-77-7)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

FAQ:

231278-84-5 - Applicatio:

5-[4-[3-Chloro-4-(3-Fluorobenzyloxy)anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde (CAS: 231278-84-4) medium est API (CAS 388082-77-7 ).(CAS 388082-77-7) medicamentum est cancri pectoris nisl Britannici GlaxoSmithKline Co evoluta. Est kinasus tyrosinus inhibitor qui efficaciter inhibere potest kinasum tyrosinum activitatis humanae epidermalis aucti receptoribus 1 et 2 (ErbB1, ErbB2).Unice variis modis agere potest, ut cancer cellae pectus incrementum capere non possit.Negat intracellulare EGFR (ErbB-1) et HER2 (ErbB-2) sites ATP, ne phosphorylationem et activitatem tumorem cellularum intercludat, descensus ordinandi signa per homogeneitatem et heterogeneitatem EGFR (ErbB-1) et HER2 (ErbB-1) interclusit. dimerization.